Terms: = Cervical cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
4 results:
1. Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.
Huang CL; Chen Y; Guo R; Mao YP; Xu C; Tian L; Liu LZ; Lin AH; Sun Y; Ma J; Tang LL
Cancer Med; 2020 Oct; 9(19):7100-7106. PubMed ID: 32794334
[TBL] [Abstract] [Full Text] [Related]
2. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
3. cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]